I18 The HDQoL depicts disease stages more comprehensively relative to generic quality of life measures: initial pilot data. (13th September 2016)

• Record Type: Journal Article
• Authors: Ho, Aileen K; Hocaoglu, Mevhibe; Gaffan, Elizabeth
• Is Part Of: Journal of neurology, neurosurgery and psychiatry. Volume 87(2016)Supplement 1
• Page Start: A65
• Page End: A65
• Publication Date: 2016-09-13
• Subjects: quality of life -- HDQol -- EQ-5D -- SF-12 -- questionnaire; Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Psychiatry -- Periodicals; 616.8
• DOI: 10.1136/jnnp-2016-314597.183
• Languages: English
• ISSNs: 0022-3050

Abstract

Abstract : Background: The importance of determining the impact of Huntington's disease (HD) on a person's health is particularly relevant given the protracted course of this condition. For this reason, the disease specific Huntington's disease quality of life (HDQoL) was developed directly from patients interviews in order to fully capture the experience of living with HD. Aims: The current study aims to examine HD impact across the spectrum of disease using a patient-derived disease-specific instrument i.e. the Huntington's Disease health-related Quality of Life questionnaire (HDQoL). Generic quality of life measures from the same cohort for the time point will be presented for comparison. Methods: An initial sample of one hundred and fifty two participants completed the HDQoL, the SF-12 and EQ-5D questionnaires, as well as a single-item global quality of life question. Results: The HDQoL scales provided the most differentiation across functional disease stages in this cross-sectional study relative to the generic measures. The HDQoL depicted a more comprehensive picture of health-related quality of life in HD from the earliest at risk and presymptomatic stages till the latter stages of disease. Non-physical emotional aspects were more negatively affected than physical health-related quality of life early on in the course of disease, before they are overtaken by the more physical aspects of HD. Conclusion: The findings demonstrate the utility of the Huntington's–specific HDQoL instrument over generic measures in capturing the true level of impact on the full range of aspects affected in Huntington's disease.